US Stock MarketDetailed Quotes

NGENF NERVGEN PHARMA CORP

Watchlist
  • 1.550
  • +0.050+3.33%
15min DelayClose Apr 26 16:00 ET
108.39MMarket Cap-5575P/E (TTM)

About NERVGEN PHARMA CORP Company

NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.

Company Profile

SymbolNGENF
Company NameNERVGEN PHARMA CORP
Founded2017
CEOMr. Michael Kelly
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address112-970 Burrard Street,Unit 1290
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6Z 2R4
Phone1-778-731-1711
Websitehttp://www.nervgen.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Kelly
  • Director, President and Chief Executive Officer
  • --
  • William J. Adams
  • Chief Financial Officer and Corporate Secretary
  • --
  • Dr. Daniel D. Mikol, M.D.
  • Chief Medical Officer
  • --
  • William Joseph Radvak
  • Chairman of the Board
  • --
  • Dr. Adam H. Rogers
  • Director
  • --
  • Krista McKerracher
  • Independent Director
  • --
  • John Craig Thompson
  • Independent Director
  • --
  • Dr. Harold Punnett
  • Independent Director
  • --
  • Glenn A. Ives
  • Independent Director
  • --
  • Dr. Randall E. Kaye,M.D.
  • Independent Director
  • --
  • Brian Eric Bayley
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg